http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc
-
iMD Companies and Subsidiary Riize Health Unveil Strategic Expansion Into the Non-Prescription Medicine Supplement Market With New Product Launch Timeline
-
Ondas Note Holder Purchases Additional $11.5 million of Convertible Notes: Funds to Drive Accelerated Expansion of Drone Business Including Focus on Defense Markets
-
Housing Market Unlikely to Thaw in 2025 Due to Affordability Challenges and 'Lock-in Effect'
-
Battery Mineral Resources Delivers Copper Concentrates Produced at Its Mineral Processing Facility at Punitaqui, Chile
-
iMD Companies and Subsidiary Riize Health Unveil Strategic Expansion Into the Non-Prescription Medicine Supplement Market With New Product Launch Timeline
-
SpaceRISE Signs Concession Contract to Deliver Europe’s IRIS² Connectivity Network
-
dSPACE and AWS: Powering Qualification for Indy Autonomous Challenge in Virtual Las Vegas Race
-
ArcelorMittal Maizières Research Leverages Stratasys’ Additive Manufacturing Solution to Achieve Significant Cost Savings, Design Flexibility and Production Efficiency
-
The Institute of Internal Auditors and ACCA Extend MoU for Three More Years
-
Dare Bioscience (DARE) Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder
-
Monster Energy's Nyjah Huston and Rayssa Leal Claim World Championship Titles in Street Skateboarding at the SLS Super Crown Competition in Brazil
-
Slate Grocery REIT Announces Distribution for the Month of December 2024
-
Ladybug Resource Group Achieves Record $9.6 Million Revenue
-
CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing
-
Meet Warpie The Wombat: The Hardworking Mascot of Warpcast's Blockchain Revolution and $WARPIE Token Ecosystem
-
Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body
-
Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)
-
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
-
FIS Named a Leader in Core Banking in IDC MarketScape
-
Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
-
Arelion Appoints New Enterprise Sales Director for EMEA
-
OneSpan Announces the Initiation of a Quarterly Cash Dividend
-
Meet Warpie The Wombat: The Hardworking Mascot of Warpcast's Blockchain Revolution and $WARPIE Token Ecosystem
-
NV5 Awarded $10 Million in Critical Mineral Geospatial Projects by U.S. Geological Survey
-
Ladybug Resource Group Achieves Record $9.6 Million Revenue
-
DZS FiberLAN Empowers One of Israel’s Most Innovative Hospitality Venues with State-of-the-Art Communications Capabilities
-
Soluna and Gynger Partner to Make Sustainable AI Computing More Accessible with Flexible Financing
-
Personalis and Tempus Expand Collaboration to Biopharma
-
Bitget Introduces LaunchX: A New Token Launch Platform Featuring Fuel Network as Its First Project
-
Nevada Lithium files Technical Report for Bonnie Claire Project. Significantly Increases the Size and Grade of Lower Zone Inferred Lithium Mineral Resources, and Reports Maiden Lithium and Boron Indic
-
Palatin Technologies (PTN) Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds
-
Organon (OGN) Announces FDA Approval of VTAMA cream
-
Realbotix Partners with Compass UOL, Receives Amazon Development Subsidy and Provides Update on Aria
-
Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds
-
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
-
FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
-
Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024
-
Frontera Announces Another CAD$42 Million (US$30 million) Substantial Issuer Bid
-
Bifrost Wallet Expands Multi-Chain Support for Bitcoin and Dogecoin in Preparation for DeFi on Songbird/Flare
-
Foghorn Therapeutics (FHTX) says efficacy threshold not achieved to support continued development of FHD-286
-
Thermal Energy Announces $2.8 Million Turn-Key Project with a Leading Pharmaceutical Company
-
Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities
-
Aston Bay Presents Corporate Update
-
Bio-Thera Solutions Expands Partnership with SteinCares in LATAM with Addition of a Third Biosimilar to Partnership
-
Gold79 Appoints Quentin Mai as CEO and Director
-
Beats on Base Releases Progress Update of its Revolutionary Meme Music Project and New AI Agents
-
Merck's (MRK) KEYTRUDA Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment
-
Merck’s KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy After Surgery as Adjuvant Treatment for Patients With Re
